OLAPARIB TABLETS APPROVAL
AstraZeneca Pharma gets CSDCO nod to import anti-cancer drug LynparzaAstraZeneca Pharma India has received regulatory approval to import and distribute Lynparza (Olaparib) tablets in 100mg and 150mg doses. Th...26 Nov, 2024, 03.00 PM IST
DCGI orders withdrawal of cancer drug Olaparib for certain treatmentsThe Drug Controller General of India has requested the withdrawal of AstraZeneca's Olaparib tablets for certain cancer treatments due to po...23 May, 2024, 12.29 AM IST
Regulator asks state bodies to limit scope of key cancer drugIndia's drug regulatory authority has instructed state-level counterparts to mandate manufacturers of Olaparib tablets in 100 mg and 150 mg...22 May, 2024, 01.41 AM IST
Load More